Life Saving Drugs Program resources – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D)

A collection of resources for health professionals to help people with infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) access sebelipase alfa (Kanuma®) under the Life Saving Drugs Program.

Collection description

View the product information for Sebelipase alfa (Kanuma®)  on the Therapeutic Goods Administration website.



We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.